Patents by Inventor David Scott Casebier

David Scott Casebier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF PROSTATE CANCER
    Publication number: 20170157148
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 8, 2017
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • NOVEL COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER
    Publication number: 20160002283
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. In some embodiments, the solid matrix comprises a polymer. In some embodiments, the polymer is soluble in an aqueous solution. In particular embodiments, the aqueous solution is water. In other embodiments, the aqueous solution has a pH of 5.0 or greater.
    Type: Application
    Filed: September 15, 2015
    Publication date: January 7, 2016
    Inventors: David Scott Casebier, Abdellah Sentissi, Richard Christian Moreton, Mark Turnbull
  • NOVEL COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER
    Publication number: 20150320770
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. In some embodiments, the solid matrix comprises a polymer. In some embodiments, the polymer is soluble in an aqueous solution. In particular embodiments, the aqueous solution is water. In other embodiments, the aqueous solution has a pH of 5.0 or greater.
    Type: Application
    Filed: July 23, 2015
    Publication date: November 12, 2015
    Inventors: David Scott Casebier, Abdellah Sentissi, Richard Christian Moreton, Mark Turnbull
  • Treatment of prostate cancer
    Patent number: 9156878
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: October 13, 2015
    Assignee: Tokai Pharmaceuticals, Inc.
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20150203528
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: March 2, 2015
    Publication date: July 23, 2015
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20150166599
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: March 2, 2015
    Publication date: June 18, 2015
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • TREATMENT OF PROSTATE CANCER
    Publication number: 20140343024
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: June 24, 2014
    Publication date: November 20, 2014
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • NOVEL COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER
    Publication number: 20140288037
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. In some embodiments, the solid matrix comprises a polymer. In some embodiments, the polymer is soluble in an aqueous solution. In particular embodiments, the aqueous solution is water. In other embodiments, the aqueous solution has a pH of 5.0 or greater.
    Type: Application
    Filed: July 18, 2012
    Publication date: September 25, 2014
    Applicant: Tokai Pharmaceuticals, Inc.
    Inventors: David Scott Casebier, Abdellah Sentissi, Richard Christian Moreton, Mark Turnbull
  • Treatment of prostate cancer
    Patent number: 8791094
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. Such compounds include inhibitors of cytochrome C17?-hydroxylase/C17,20-lyase such as 3-?-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: July 29, 2014
    Assignee: Tokai Pharmaceuticals, Inc.
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • Treatment of Prostate Cancer
    Publication number: 20110034428
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.
    Type: Application
    Filed: August 5, 2010
    Publication date: February 10, 2011
    Applicant: TOKAI PHARMACEUTICALS, INC.
    Inventors: Jodie Pope Morrison, Cy Aaron Stein, David Scott Casebier
  • Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
    Publication number: 20100120725
    Abstract: Compounds of Formula I, wherein R1-R8 are defined herein are provided, together with pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof. Uses of these compounds for inhibiting beta amyloid production and for the prevention and treatment of Alzheimer's disease and Down's syndrome are also described.
    Type: Application
    Filed: January 21, 2010
    Publication date: May 13, 2010
    Applicants: Wyeth LLC, ArQule, Inc.
    Inventors: Anthony Frank Kreft, Derek Cecil Cole, Kevin Roger Woller, Joseph Raymond Stock, Kristina Martha Kutterer, Dennis Martin Kubrak, Charles William Mann, William Jay Moore, David Scott Casebier
  • Substituted phenylsulfonamide inhibitors of beta amyloid production
    Patent number: 7671075
    Abstract: Compounds of Formula I, wherein R1-R8 are defined herein are provided, together with pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof. Uses of these compounds for inhibiting beta amyloid production and for the prevention and treatment of Alzheimer's Disease and Down's syndrome are also described.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: March 2, 2010
    Assignees: Wyeth, ArQule, Inc.
    Inventors: Anthony Frank Kreft, Derek Cecil Cole, Kevin Roger Woller, Joseph Raymond Stock, Kristina Martha Kutterer, Dennis Martin Kubrak, Charles William Mann, William Jay Moore, David Scott Casebier
  • Substituted phenylsulfonamide inhibitors of beta amyloid production
    Patent number: 7166622
    Abstract: Compounds of Formula I, wherein R1–R8 are defined herein are provided, together with pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof. Uses of these compounds for inhibiting beta amyloid production and for the prevention and treatment of Alzheimer's Disease and Down's syndrome are described.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: January 23, 2007
    Assignees: Wyeth, ArQule, Inc.
    Inventors: Anthony Frank Kreft, Derek Cecil Cole, Kevin Roger Woller, Joseph Raymond Stock, Kristina Martha Kutterer, Dennis Martin Kubrak, Charles William Mann, William Jay Moore, David Scott Casebier
  • Substituted phenylsulfonamide inhibitors of beta amyloid production
    Publication number: 20040006050
    Abstract: Compounds of Formula I, 1
    Type: Application
    Filed: June 9, 2003
    Publication date: January 8, 2004
    Applicants: Wyeth, ArQule Inc.
    Inventors: Anthony Frank Kreft, Derek Cecil Cole, Kevin Roger Woller, Joseph Raymond Stock, Kristina Martha Kutterer, Dennis Martin Kubrak, Charles William Mann, William Jay Moore, David Scott Casebier